多重用药与社区老年人肾功能的前瞻性观察研究
该研究基于苏黎世膝关节骨关节炎维生素D试验的270名社区老年人(平均70.3岁),前瞻性观察24个月内药物总数及NSAIDs累积使用与eGFR变化的关系。结果显示,基线每多一种药物,24个月eGFR多下降0.64 mL/min/1.73 m2;累积每多一种药物多下降0.39;高危亚组累积每多一种NSAID多下降1.21。
要点
- 社区老年人每增加一种药物,24个月eGFR独立下降0.64 mL/min/1.73 m2。
- 累积用药每增加一种,eGFR下降0.39 mL/min/1.73 m2,呈即时有害关联。
- 高危亚组累积每增加一种NSAID,eGFR下降1.21 mL/min/1.73 m2,约为普通药物3倍。
核心结论
- 老年人每多处方一种药物,对肾功能存在独立且即时的有害影响。
- NSAIDs对肾功能的负面影响约为每增加一种平均药物的3倍。
研究设计与样本
- 前瞻性观察分析,嵌套于为期2年的苏黎世膝关节骨关节炎患者多重终点维生素D试验。
- 共纳入270名社区老年人,平均年龄70.3±6.4岁,女性占53%。
主要发现
- 基线每多一种药物,24个月eGFR下降0.64 mL/min/1.73 m2(Beta=-0.64;95%CI -1.19至-0.08;P=.024)。
- 24个月内累积每多一种药物,eGFR下降0.39 mL/min/1.73 m2(Beta=-0.39;95%CI -0.63至-0.15;P=.002)。
- 高危亚组24个月内累积每多一种NSAID,eGFR下降1.21 mL/min/1.73 m2(Beta=-1.21;95%CI -2.35至-0.07;P=.021)。
临床怎么用
- 对社区老年人处方时应关注药物总数对肾功能的即时累积损害,尤其慎用NSAIDs。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Information on the impact of polypharmacy on kidney function in older adults is limited. We prospectively investigated the association between intake of total number of drugs or nonsteroidal anti-inflammatory drugs (NSAIDs) and kidney function. DESIGN: Our study is a prospective observational analysis of the 2-year Zurich Multiple Endpoint Vitamin D Trial in Knee Osteoarthritis Patients. SETTING AND PARTICIPANTS: Of the 273 participants of the original trial, 270 participants (mean age 70.3 ± 6.4 years, 53% women) were included in this observational analysis. METHODS: The associations between (1) total number of drugs (or NSAIDs) at baseline or (2) cumulative number of drugs (or NASAIDs) repeatedly measured over 24 months and kidney function repeatedly measured over 24 months as estimated glomerular filtration rate (eGFR) were investigated using multivariable-adjusted repeated-measures analysis. RESULTS: Per drug at baseline, kidney function decreased by 0.64 mL/min/1.73 m2 eGFR (Beta = -0.64; 95% CI -1.19 to -0.08; P = .024) over 24 months. With every additional drug taken cumulatively over 24 months, kidney function decreased by 0.39 mL/min/1.73 m2 eGFR (Beta = -0.39; 95% CI -0.63 to -0.15; P = .002). In a high-risk subgroup, per NSAID taken cumulatively over 24 months, kidney function declined by 1.21 mL/min/1.73 m2 eGFR (Beta = -1.21; 95% CI -2.35 to -0.07; P = .021). CONCLUSIONS AND IMPLICATIONS: For every additional drug prescribed among older adults, our study supports an independent and immediate harmful impact on kidney function. This negative impact seems to be about 3 times greater for NSAIDs compared with an additional average drug.
引用
- Ernst R, Fischer K, de Godoi Rezende Costa Molino C, et al. Polypharmacy and Kidney Function in Community-Dwelling Adults Age 60 Years and Older: A Prospective Observational Study. J Am Med Dir Assoc. 2019. PMID: 31501003. doi:10.1016/j.jamda.2019.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。